Full-year consolidated earnings forecast for the year ending June 2026 was raised. Revenue from 3,860 million yen to 3,871 million yen; operating income from -180 million yen to 275 million yen; and other segment adjustments. Profitability improvements are progressing in Healthcare Support and Dietary Supplements.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2385","jir_company_name":"Total Medical Research Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/2385-20260812-02.pdf","jir_short_summary":"Full-year consolidated earnings forecast for the year ending June 2026 was raised. Revenue from 3,860 million yen to 3,871 million yen; operating income from -180 million yen to 275 million yen; and other segment adjustments. Profitability improvements are progressing in Healthcare Support and Dietary Supplements.","jir_summary":"### Section heading\nThis report discloses revised details on the difference between the full-year consolidated earnings forecast for the year ending June 2026 and actual results. Through progress in structural reforms from the third quarter onward and the effects of profitability-improvement measures, the earnings outlook has been raised. By segment, improved profitability in Healthcare Support and Dietary Supplements, along with cost reductions and internalization of development, contribute to the improvements.\n\n### Second section heading\nAs for the outlook, the factors that led to actual results exceeding the full-year consolidated forecast for this term are expected to strengthen the earnings base for the next term and beyond. There is no currency impact described in the text. Segment-level profit improvements contribute to the overall profit rise, and strategies in healthcare-related and cosmetics\/dietary supplement areas are bearing fruit.","jir_financial_highlights":"Revenue: 3,871 \u767e\u4e07\u5186 (From previous forecast 3,860 \u767e\u4e07\u5186 to +11 \u767e\u4e07\u5186)\nOperating income: 275 \u767e\u4e07\u5186 (From previous forecast 200 \u767e\u4e07\u5186 to +75 \u767e\u4e07\u5186)\nOrdinary income: 287 \u767e\u4e07\u5186 (From previous forecast 215 \u767e\u4e07\u5186 to +72 \u767e\u4e07\u5186)\nNet income attributable to owners of parent: 212 \u767e\u4e07\u5186 (From previous forecast 120 \u767e\u4e07\u5186 to +92 \u767e\u4e07\u5186)","jir_category":"","jir_hashtags":"#\u7dcf\u533b\u7814\u30db\u30fc\u30eb\u30c7\u30a3\u30f3\u30b0\u30b9, #\u696d\u7e3e\u4e88\u60f3\u4fee\u6b63","jir_key_figures":"Revenue: 3,871 \u767e\u4e07\u5186\nOperating income: 275 \u767e\u4e07\u5186\nOrdinary income: 287 \u767e\u4e07\u5186","jir_meta_title":"\u3010\u7dcf\u533b\u7814\u30db\u30fc\u30eb\u30c7\u30a3\u30f3\u30b0\u30b9\u3011 Earnings Forecast Revision Announced\uff5cYear Ending June 2026","jir_meta_description":"S\u014diken Holdings announces an upward revision of its full-year consolidated earnings forecast for the year ending June 2026. This IR notice outlines projections for revenue, operating income, ordinary income, net income, and segment contributions.","jir_og_title":"S\u014diken Holdings Earnings Forecast Revision Announced\uff5cYear Ending June 2026","jir_og_description":"S\u014diken Holdings raises its earnings forecast for the current term. Explanations of segment-level improvement factors and the strategy to strengthen the earnings base going forward are provided.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59673,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-102404","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n